Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether any senior directors of NHS England were paid performance bonuses in financial years (a) 2023-24 and (b) 2024-25.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
NHS England publishes the performance bonus information for its national directors in their annual accounts. No national directors were paid a bonus in 2023/24, and bonuses will not be paid for 2024/25. NHS England’s latest annual report and accounts has been published and is available at the following link:
https://www.gov.uk/government/publications/nhs-england-annual-report-and-accounts-2023-to-2024
The following table shows the latest published Executive Senior Manager (ESM) pay framework from 2021, which applies to the East of England region:
Role grade | Pay bands | ||
Minimum | Operational max | Max exception zone | |
ESM 1 | £90,900 | £113,625 | £131,300 |
ESM 2 | £131,301 | £146,450 | £161,600 |
ESM 3 | £161,601 | £176,750 | £191,900 |
ESM 4 | £191,901 | £207,050 | £222,200 |
Although not all posts are currently filled, the number of permanent posts by grade in the region are as follows:
NHS England’s regional communications functions are currently centrally employed. This resource is then provided to regions to support their work. There are eight posts, specifically seven staff and one vacancy, providing communications, media, and engagement support to the National Health Service in the East of England in meeting its statutory and constitutional responsibilities on engaging with the public and helping patients find the right services.
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many (a) communications and (b) media staff are employed by NHS East of England.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
NHS England publishes the performance bonus information for its national directors in their annual accounts. No national directors were paid a bonus in 2023/24, and bonuses will not be paid for 2024/25. NHS England’s latest annual report and accounts has been published and is available at the following link:
https://www.gov.uk/government/publications/nhs-england-annual-report-and-accounts-2023-to-2024
The following table shows the latest published Executive Senior Manager (ESM) pay framework from 2021, which applies to the East of England region:
Role grade | Pay bands | ||
Minimum | Operational max | Max exception zone | |
ESM 1 | £90,900 | £113,625 | £131,300 |
ESM 2 | £131,301 | £146,450 | £161,600 |
ESM 3 | £161,601 | £176,750 | £191,900 |
ESM 4 | £191,901 | £207,050 | £222,200 |
Although not all posts are currently filled, the number of permanent posts by grade in the region are as follows:
NHS England’s regional communications functions are currently centrally employed. This resource is then provided to regions to support their work. There are eight posts, specifically seven staff and one vacancy, providing communications, media, and engagement support to the National Health Service in the East of England in meeting its statutory and constitutional responsibilities on engaging with the public and helping patients find the right services.
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what information his Department holds on when the Mid and South Essex NHS Foundation Trust plans to publish it's 2024-25 Annual Report.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Annual Report and Accounts of the Mid and South Essex NHS Foundation Trust for 2024/2025 will be published ahead of the trust’s Annual General Meeting, which is usually held at the end of September. Publication can only take place after the Annual Report and Accounts have been laid before Parliament, in line with NHS England guidance.
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what role Price Waterhouse Coopers have been assigned in assisting with the financial management of the Mid & South Essex NHS Hospitals Trust; how long this task has been assigned for; what the cost to the public purse is; and what outputs they are required to deliver.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
PricewaterhouseCoopers (PwC) received a direct award to undertake a nationally mandated Investigation and Intervention programme at the Mid and South Essex Integrated Care Board, to support it in delivering its financial plan.
The programme lasted eight weeks, and the cost of phase one was £246,187, which the Mid and South Essex NHS Foundation Trust and the integrated care board incurred. The output was a report recommending actions the system should take to recover its in-year plan.
The Mid and South Essex Integrated Care Board decided to secure additional support from PwC for phase two from mid-July to the end of October 2024, which cost £1.07 million. This evolved into a programme of work supporting direct intervention within and across the foundation trust’s hospital sites.
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the salary bands are for the Managing Director of (a) Southend Hospital, (b) Basildon Hospital and (c) Broomfield hospital; and when the people in these roles were appointed.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department does not hold the information requested. Information on the renumeration and biographies of senior staff are published by hospital trusts as part of their annual report and accounts. This information for the Mid and South Essex Hospitals Trust, including biographies of senior staff, is available at the following link:
https://www.mse.nhs.uk/trust-publications-and-reports?smbfolder=150
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the salary bands are for the (a) Chief Executive, (b) Chief Operating Officer, (c) Finance Director and (d) Medical Director at Mid & South Essex Hospitals NHS Trust.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Information on the renumeration of senior staff is published by hospital trusts as part of their annual report and accounts. This information for the Mid and South Essex Hospitals Trust is available at the following link:
https://www.mse.nhs.uk/trust-publications-and-reports?smbfolder=150
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many (a) communications and (b) media staff are employed by Mid & South Essex Hospitals NHS Trust.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department does not hold the information requested.
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many equality, diversity and inclusion managers are employed by the Mid and South Essex Hospitals NHS Trust.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department does not hold the information requested.
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of five-year survival rates for (a) acute myeloid leukaemia and (b) other leukaemias.
Answered by Andrew Gwynne
The age-standardised, one-year net survival for adults, those aged 15 to 99 years old, diagnosed with leukaemia between 2016 and 2020 in England was 74.4%, and the five-year survival rate was 55.9%.
NHS England has implemented non symptom specific pathways for patients who present with non-specific symptoms or combinations thereof, that can indicate several different cancers. This includes leukaemia, which can present non-specific symptoms, such as unexpected weight loss and night sweats. The national evaluation showed that blood cancers are one of the most common cancer types diagnosed through these pathways.
Raising awareness, delivering more research, including into new treatments, and improving early diagnosis of cancers, which includes blood related cancers such as leukaemia, are crucial for improving cancer survival.
Cancer patients are being failed, waiting too long for a diagnosis and treatment. We will bring down waits for cancer appointments with the Fit For the Future fund, doubling the number of state-of-the-art magnetic resonance imaging and computed tomography in the National Health Service to ensure early diagnosis and faster treatment.
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans he has to implement a cancer strategy over the course of this Parliament.
Answered by Andrew Gwynne
Professor Lord Darzi is currently undertaking an independent investigation into the state of the National Health Service, the findings of which will feed into the Government’s 10-year plan to build a health service that is fit for the future. The Government will set out any further priorities on cancer and health in due course.
The NHS Long-Term Plan, published in January 2019, sets out the NHS’s key ambitions on cancer. The plan sets out the ambition to increase the number of cancers diagnosed at stage one and two to 75% by 2028, and to increase the number of people surviving cancer for five years by 55,000 as a result.